Cargando…

Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design

BACKGROUND AND PURPOSE: Tenecteplase (TNK) is a promising agent for treatment of acute ischaemic stroke (AIS). We hypothesised that recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) is non-inferior to rt-PA in achieving excellent functional outcome at 90 days, when administered wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuya, Campbell, Bruce C V, Schwamm, Lee H, Fisher, Marc, Parsons, Mark, Li, Hao, Pan, Yuesong, Wang, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899655/ https://www.ncbi.nlm.nih.gov/pubmed/34446531 http://dx.doi.org/10.1136/svn-2021-001074

Ejemplares similares

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
por: Li, Shuya, et al.
Publicado: (2021)

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
por: Wang, Yongjun, et al.
Publicado: (2021)

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications
por: Wang, Yongjun
Publicado: (2021)

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)

Tenecteplase Thrombolysis in Posterior Circulation Stroke
por: Alemseged, Fana, et al.
Publicado: (2021)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Chinese Atherosclerosis Risk Evaluation (CARE II) study: a novel cross-sectional, multicentre study of the prevalence of high-risk atherosclerotic carotid plaque in Chinese patients with ischaemic cerebrovascular events—design and rationale
por: Zhao, Xihai, et al.
Publicado: (2017)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
por: Pan, Yuesong, et al.
Publicado: (2022)

Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
por: Eltoft, Agnethe, et al.
Publicado: (2022)

Essen score in the prediction of cerebrovascular events compared with cardiovascular events after ischaemic stroke or transient ischaemic attack: a nationwide registry analysis
por: LI, Long, et al.
Publicado: (2022)

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
por: Wang, Yongjun, et al.
Publicado: (2019)

Trail Toward Tenecteplase
por: Srivastava, Trilochan, et al.
Publicado: (2022)

Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry
por: Wang, Yongjun, et al.
Publicado: (2020)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Zhang, Lei, et al.
Publicado: (2021)

A new dawn of preventing dementia by preventing cerebrovascular diseases
por: Pan, Yuesong, et al.
Publicado: (2020)

Tenecteplase in Ischemic Stroke: Challenge and Opportunity
por: Li, Guangshuo, et al.
Publicado: (2022)

The cerebral circulation and cerebrovascular disease II: Pathogenesis of cerebrovascular disease
por: Chandra, Ankush, et al.
Publicado: (2017)

Expanding Footprints of Biosimilar Tenecteplase
por: Subhash, et al.
Publicado: (2023)

China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
por: Liu, Liping, et al.
Publicado: (2021)

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
por: Liu, Liping, et al.
Publicado: (2020)

Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China
por: Li, Zixiao, et al.
Publicado: (2022)

Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
por: Gu, Hong-Qiu, et al.
Publicado: (2020)

Intracoronary tenecteplase in STEMI with massive thrombus
por: Jayagopal, P.B., et al.
Publicado: (2018)

Tenecteplase: Haemorrhagic pericarditis: case report
Publicado: (2020)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

Misinterpretation of ischaemic infarct location in relationship to the cerebrovascular territories
por: Hartkamp, Nolan S, et al.
Publicado: (2016)

The impact of acute remote ischaemic preconditioning on cerebrovascular function
por: Carter, Howard H., et al.
Publicado: (2020)

Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke
por: Suo, Yue, et al.
Publicado: (2020)

Distribution and prognosis of acute ischaemic stroke with negative diffusion-weighted imaging
por: Wang, Yu, et al.
Publicado: (2022)

Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design
por: Levin, Bruce, et al.
Publicado: (2011)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning
por: Liu, Shi-Meng, et al.
Publicado: (2018)

Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy
por: Zdolińska-Malinowska, Izabela, et al.
Publicado: (2022)

Pharmacological brain cytoprotection in acute ischaemic stroke — renewed hope in the reperfusion era
por: Fisher, Marc, et al.
Publicado: (2022)

Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
por: Melandri, Giovanni, et al.
Publicado: (2009)

Early Experience With Tenecteplase at a Comprehensive Stroke Center
por: Panezai, Spozhmy, et al.
Publicado: (2021)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b291g4elkj6p0ojj7i65askn0v